COMMUNIQUÉS West-GlobeNewswire

Grand débat sur les soins de santé au Canada
01/06/2018
Pleins feux sur la santé mentale, la santé autochtone et la santé des aînés Un choc des idées est à prévoir à St. John’s OTTAWA, 01 juin 2018 (GLOBE NEWSWIRE) -- La semaine prochaine, les leaders en santé du Canada [...]
NICOX : Nulber of voting rights as of May 31, 2018
01/06/2018
Nicox SA Société anonyme with a registered capital of € 29,588,510 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On June 1, 2018, MONTHLY PUBLICATION OF THE [...]
NICOX : Nombre de droits de vote au 31 mai 2018
01/06/2018
Nicox SA Société anonyme au capital de 29 588 510 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 1 er juin 2018, PUBLICATION MENSUELLE DU NOMBRE D' [...]
Sensorion to Present at the 2018 BIO International Convention
01/06/2018
MONTPELLIER, France, June 01, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, will present at the 25 th BIO International Convention at [...]
Bavarian Nordic to Present at Jefferies 2018 Healthcare Conference in New York City
01/06/2018
COPENHAGEN, Denmark - June 1, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that Paul Chaplin, President & Chief Executive Officer will provide a corporate presentation at the Jefferies 2018 [...]
Celldex Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
01/06/2018
HAMPTON, N.J., June 01, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that Anthony Marucci, Co-founder, President and Chief Executive Officer, will present a corporate overview at the [...]
Major shareholder notification – Marathon Asset Management LLP
01/06/2018
Today, GN Store Nord has received information that Marathon Asset Management LLP has decreased its holdings of GN shares. Marathon Asset Management LLP thereby holds less than 5% of the share capital and the voting [...]
Axiom Real-Time Metrics Showcasing Fusion eClinical Suite at the ASCO Annual Meeting 2018 in Chicago
01/06/2018
TORONTO, June 01, 2018 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics, premier provider of unified eClinical solutions and services, is exhibiting at the ASCO Annual Meeting from June 2-4, 2018. The 2018 ASCO Annual [...]
Cambrex to Present at the Jefferies 2018 Global Healthcare Conference
01/06/2018
EAST RUTHERFORD, N.J., June 01, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that [...]
ZoomMed and KDA Group Join Forces to Distribute the ZRx Prescriber in the United States
01/06/2018
MONTREAL, June 01, 2018 (GLOBE NEWSWIRE) -- ZoomMed Inc . (the “Corporation” or “ZoomMed”) (TSX Venture Exchange:ZMD) and KDA Group Inc . (“KDA”) (TSX Venture Exchange:KDA) are proud to announce an agreement whereby [...]
ZoomMed et Groupe KDA unissent leurs efforts pour la distribution du Prescripteur ZRx aux États-Unis
01/06/2018
MONTRÉAL, 01 juin 2018 (GLOBE NEWSWIRE) -- ZoomMed Inc. (la « Société » ou « ZoomMed ») (Bourse de Croissance TSX:ZMD) et Groupe KDA Inc. (« KDA ») (Bourse de Croissance TSX:KDA) sont fiers d’annoncer la signature d’un [...]
Trading in Coloplast shares by board members, executives or associated persons
01/06/2018
Nasdaq Copenhagen 1 June 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on the [...]
Trading in Coloplast shares by board members, executives or associated persons
01/06/2018
Nasdaq Copenhagen 1 June 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on the [...]
Vistin Pharma ASA : Completion of subsequent repair issue, registration of share capital increase
01/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
Oncolytics Biotech® Prices USD $8,000,000 Million Public Offering of Common Shares
01/06/2018
CALGARY, Alberta and SAN DIEGO, June 01, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX:ONC) (NASDAQ:ONCY), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]
Canada House Wellness Group Continues Strategic Transformation with Appointment of New Chief Executive Officer and Change to Board of Directors
01/06/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 01, 2018 (GLOBE NEWSWIRE) -- The Board of Directors of Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or [...]
Lundbeck and Otsuka’s Rxulti® (brexpiprazole) receives positive opinion in EU from CHMP for the treatment of schizophrenia in adults
01/06/2018
Press release Valby, 1 June 2018 A final decision from the European Commission is expected within 67 days. H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announce that the Committee for [...]
CV Sciences, Inc. Settles SEC Matter
01/06/2018
The Company Names New Chief Executive Officer, President and Board Member LAS VEGAS, June 01, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it [...]
SELLAS Life Sciences Provides Clinical Update on Phase 2b NeuVax™ (nelipepimut-S) Study in Combination with Trastuzumab in HER2 1+/2+ Breast Cancer Patients
01/06/2018
Phase 2b trial met key clinical objectives and is being discontinued early by the sponsor Clinical and regulatory meetings held at the American Society of Clinical Oncology (ASCO) conference Dr. Jeffrey S. Weber, [...]

Pages